Chemical Compound

Ginsenoside Rh2

CAS Registry Number 78214-33-2
Ginsenoside Rh2 chemical structure
Primary Record

Ginsenoside Rh2

In stock
6,364 g
Purity
99.0 %
CAS
78214-33-2

Compound Identifiers & Properties

CAS
78214-33-2
PubChem CID
14081290
SMILES
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C
Canonical SMILES
CC(C)=CCCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C

Names & Synonyms

  • Ginsenoside Rh2
  • Ginsenoside-Rh2
  • (20R)-Ginsenoside Rh2
  • 20(R)-Ginsenoside Rh2
  • (R)-Ginsenoside Rh2
  • 20(R)Ginsenoside Rh2
  • RefChem:1092765
  • 20(S)-Ginsenoside Rh2
  • 20(S)- Ginsenoside Rh2
  • Ginsenoside Rh2 (S-FORM)
  • Npc168272
  • SCHEMBL27814796
  • CHEBI:172776
  • 78214-33-2
  • BCP10285
  • BCP23574
  • C36H62O8
  • SCA40017
  • MFCD22200425
  • EBC-616932
  • LS-15384
  • 112246-15-8
  • 67400-17-3
  • 20(S)-Ginsenoside Rh2; 20(S)-Rh2; Ginsenoside-Rh2
  • (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl beta-D-glucopyranoside
  • (2R,3R,4S,5S,6R)-2-[[(3R,8R,10R,12S,13S,14S,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • (S)-(3b,12b)-12,20-dihydroxydammar-24-en-3-yl b-D-glucopyranoside
  • (S)-(3b,12b)-12,20-Dihydroxydammar-24-en-3-yl beta-D-glucopyranoside
  • 2-[[12-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • (3B,12B)-12,20-DIHYDROXYDAMMAR-24-EN-3-YL ALPHA-D-GLUCOPYRANOSIDE
  • 3-O-(c)micro-D-Glucopyranoside pound>>(R)Ginsenoside-Rh2 pound>>20(R)-Ginsenoside
  • (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
  • 2-[[12-hydroxy-17-(1-hydroxy-1,5-dimethyl-hex-4-enyl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
  • 2-{[11-hydroxy-1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
  • 2-{[11-hydroxy-1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol